Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Neuro-Oncology
|
October 26, 2013
A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival
Benjamin Kefas, Desiree H Floyd, Laurey Comeau, et al.
The Journal of Experimental Medicine
|
April 21, 2004
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation
Emmanuel Zorn, David B Miklos, Blair H Floyd, et al.
Transplantation
|
June 29, 2011
Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation
Fabrice Porcheray, David B Miklos, Blair H Floyd, et al.
The Biochemical Journal
|
April 4, 2001
Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor
J Munday, S Kerr, J Ni, et al.
Blood
|
June 24, 2005
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
Emmanuel Zorn, Haesook T Kim, Stephanie J Lee, et al.
Journal of Cellular Biochemistry
|
February 9, 2008
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice
Ozge Uluçkan, Mark C Eagleton, Desiree H Floyd, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 4, 2009
The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors
Benjamin Kefas, Laurey Comeau, Desiree H Floyd, et al.
Cancer Discovery
|
April 6, 2013
Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers
Charli L Dominguez, Desiree H Floyd, Aizhen Xiao, et al.
Bone
|
May 16, 2009
The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts
Angela C Hirbe, Anke J Roelofs, Desiree H Floyd, et al.
The Journal of Biological Chemistry
|
December 9, 2008
Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases
Zhiqiang Xu, Michelle A Hurchla, Hongju Deng, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Neuro-Oncology
|
October 26, 2013
A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival
Benjamin Kefas, Desiree H Floyd, Laurey Comeau, et al.
The Journal of Experimental Medicine
|
April 21, 2004
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation
Emmanuel Zorn, David B Miklos, Blair H Floyd, et al.
Transplantation
|
June 29, 2011
Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation
Fabrice Porcheray, David B Miklos, Blair H Floyd, et al.
The Biochemical Journal
|
April 4, 2001
Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor
J Munday, S Kerr, J Ni, et al.
Blood
|
June 24, 2005
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
Emmanuel Zorn, Haesook T Kim, Stephanie J Lee, et al.
Journal of Cellular Biochemistry
|
February 9, 2008
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice
Ozge Uluçkan, Mark C Eagleton, Desiree H Floyd, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 4, 2009
The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors
Benjamin Kefas, Laurey Comeau, Desiree H Floyd, et al.
Cancer Discovery
|
April 6, 2013
Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers
Charli L Dominguez, Desiree H Floyd, Aizhen Xiao, et al.
Bone
|
May 16, 2009
The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts
Angela C Hirbe, Anke J Roelofs, Desiree H Floyd, et al.
The Journal of Biological Chemistry
|
December 9, 2008
Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases
Zhiqiang Xu, Michelle A Hurchla, Hongju Deng, et al.
Page
of 6